These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 34872623)

  • 1. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management.
    Aslan A; Aslan C; Zolbanin NM; Jafari R
    Pneumonia (Nathan); 2021 Dec; 13(1):14. PubMed ID: 34872623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
    Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
    CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated acute respiratory distress syndrome versus classical acute respiratory distress syndrome (a narrative review).
    Krynytska I; Marushchak M; Birchenko I; Dovgalyuk A; Tokarskyy O
    Iran J Microbiol; 2021 Dec; 13(6):737-747. PubMed ID: 35222850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
    Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
    Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 pandemic: overview of protective-ventilation strategy in ARDS patients.
    Higny J; Feye F; Forêt F
    Acta Clin Belg; 2021 Dec; 76(6):509-511. PubMed ID: 32340583
    [No Abstract]   [Full Text] [Related]  

  • 9. Ventilatory Management of Patients with Acute Respiratory Distress Syndrome Due to SARS-CoV-2.
    Jacquier M; Labruyère M; Ecarnot F; Roudaut JB; Andreu P; Voizeux P; Save Q; Pedri R; Rigaud JP; Quenot JP
    J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

  • 11. The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.
    Rayner-Hartley E; Miller PE; Burstein B; Bibas L; Goldfarb M; Rampersad P; van Diepen S
    Can J Cardiol; 2020 Oct; 36(10):1675-1679. PubMed ID: 32712309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study.
    Grasselli G; Tonetti T; Protti A; Langer T; Girardis M; Bellani G; Laffey J; Carrafiello G; Carsana L; Rizzuto C; Zanella A; Scaravilli V; Pizzilli G; Grieco DL; Di Meglio L; de Pascale G; Lanza E; Monteduro F; Zompatori M; Filippini C; Locatelli F; Cecconi M; Fumagalli R; Nava S; Vincent JL; Antonelli M; Slutsky AS; Pesenti A; Ranieri VM;
    Lancet Respir Med; 2020 Dec; 8(12):1201-1208. PubMed ID: 32861276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?
    Fan E; Beitler JR; Brochard L; Calfee CS; Ferguson ND; Slutsky AS; Brodie D
    Lancet Respir Med; 2020 Aug; 8(8):816-821. PubMed ID: 32645311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventilation management in acute respiratory failure related to COVID-19 versus ARDS from another origin - a descriptive narrative review.
    Tsonas AM; Botta M; Serpa Neto A; Horn J; Paulus F; Schultz MJ
    Expert Rev Respir Med; 2021 Aug; 15(8):1013-1023. PubMed ID: 33847219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) for Immunomodulation in COVID-19 Related Acute Respiratory Distress Syndrome (ARDS).
    Velotti F; Costantini L; Merendino N
    J Clin Med; 2022 Dec; 12(1):. PubMed ID: 36615103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute respiratory failure in the course of COVID-19. Practical hints from the expert panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society.
    Czajkowska-Malinowska M; Kania A; Kuca PJ; Nasiłowski J; Skoczyński S; Sokołowski R; Śliwiński PS
    Adv Respir Med; 2020; 88(3):245-266. PubMed ID: 32706108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages.
    Ammar MA; Sacha GL; Welch SC; Bass SN; Kane-Gill SL; Duggal A; Ammar AA
    J Intensive Care Med; 2021 Feb; 36(2):157-174. PubMed ID: 32844730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis.
    Dmytriw AA; Chibbar R; Chen PPY; Traynor MD; Kim DW; Bruno FP; Cheung CC; Pareek A; Chou ACC; Graham J; Dibas M; Paranjape G; Reierson NL; Kamrowski S; Rozowsky J; Barrett A; Schmidt M; Shahani D; Cowie K; Davis AR; Abdelmegeed M; Touchette JC; Kallmes KM; Pederson JM; Keesari PR
    Expert Rev Respir Med; 2021 Oct; 15(10):1347-1354. PubMed ID: 33882768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.